Genomenon Valuation Estimate
Genomenon Valuation as of Last Funding Round
Genomenon Company Overview
Genomenon is a healthcare technology company that specializes in genomic intelligence for genetic disease and cancer. Their Mastermind platform transforms complex genetic data into actionable insights, accelerating Next-Generation Sequencing (NGS) variant interpretation with comprehensive search and insight into the full text of genomic literature. Genomenon's Mastermind 3.0 offers a Gene Information Page that provides comprehensive gene information and ACMG gene-wide parameters for variant interpretation in large panels, whole exomes, and genomes. The company has been awarded the 2023 Global Technology Innovation Leadership Award by Frost & Sullivan
Genomenon Valuation History
Genomenon Stock Price
The stock price of Genomenon can be calculated by taking the valuation of the company divided by the number of shares outstanding. Because a private company can issue new shares at any time, we do not know the current number of shares outstanding.
For illustrative purposes, however, assuming Genomenon has issued 250 million shares, at the estimated UpMarket valuation of $64.31 million, each share of Genomenon stock would be worth $0.26.
Buy Genomenon Stock
If you would like to buy shares in Genomenon, please provide your information in the form at the top of this page and click the button titled “I want to buy this stock.”
One of our investor relations team members will contact you to discuss Genomenon stock availability. Note: inquiries are non-binding and shares may only be purchased by accredited investors that meet all eligibility criteria.
UpMarket has offered many similar companies as Pre-IPO investments, including Airbnb, SpaceX, ByteDance, Plaid, Kraken, Databricks, and others. UpMarket also often has funds available that invest in a portfolio of companies potentially including, Genomenon as well.
Genomenon Management
Name | Position |
---|---|
Mike Klein | CEO |
Sam Globus | COO |